Please use this identifier to cite or link to this item:
https://hdl.handle.net/2440/33075
Citations | ||
Scopus | Web of ScienceĀ® | Altmetric |
---|---|---|
?
|
?
|
Type: | Conference item |
Title: | A phase 1 study of the GM-CSF antagonist E21R |
Author: | Olver, I. Vadas, M. Lopez, A. Keefe, D. Taylor, A. Brown, M. To, L. |
Citation: | Proceedings of ASCO - Volume 19 2000, 2000, pp.475a-475a |
Publisher: | American Society of Clinical Oncology |
Publisher Place: | USA |
Issue Date: | 2000 |
Conference Name: | ASCO - Volume 19 2000 |
DOI: | 10.999/1234 |
Appears in Collections: | Aurora harvest Medicine publications |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.